Mathieu Chevrier

Stock Analyst at Citigroup

(2.55)
# 2,254
Out of 4,876 analysts
2
Total ratings
100%
Success rate
13.98%
Average return
Main Sectors:

Stocks Rated by Mathieu Chevrier

ResMed
Mar 5, 2025
Upgrades: Buy
Price Target: n/a
Current: $255.16
Upside: -